谷歌Chrome浏览器插件
订阅小程序
在清言上使用

Renal cell carcinoma in the coming era of robotic technology]

Ivan Kolombo,Jirí Ponesický, Michal Toberný, Radko Kríz, Iva Zemanová,Jirí Weichet, Josef Vymazal, Stanislav Cernohorský,Milan Bartůnek

Casopís lékar̆ů c̆eských(2011)

引用 23|浏览0
暂无评分
摘要
Renal cell carcinoma is the most malignant urological tumour and the incidence in the Czech Republic is currently highest in the world. Kidney cancer is associated with seven different genes and is characterized nowadays as metabolic disease. Authors present some current facts about advances in diagnosis and new treatment methods. Different findings required individual approach. Diagnosis improved with more sophisticated ultrasonography, computed tomography, magnetic resonance imaging and positron emission tomography etc. Apart from standard surgery new alternative methods of minimally invasive procedures also assert (laparoscopy, robotic surgery, radiofrequency ablation, kryoablation) and are incorporated in current complex treatment strategies. Systemic therapy with new targeted antiangiogenics drugs is a new standard of treatment for metastatic kidney cancer Complex care with integration of local treatment (surgery, radiotherapy, selective embolization, radiosurgery, cementoplasty, vetrebroplasty etc.) and systemic medication with best supportive care is optimal for a metastatic kidney cancer. More accurate diagnostic methods and complex interdisciplinary approach with integration of systemic therapy with new targeted drugs and new minimally invasive procedures represent new possibilities for patients with kidney cancer.
更多
查看译文
关键词
renal cell carcinoma,robotic technology
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要